Cargando…

Impact of Pulmonary Rehabilitation Services in Patients with Different Lung Diseases

Background: the effect of pulmonary rehabilitation (PR) services, beyond research contexts, on patients with lung diseases other than COPD requires further study. Objectives: to (i) assess the impact of a publicly funded PR on patients’ exercise capacity, self-efficacy, and health-related quality of...

Descripción completa

Detalles Bibliográficos
Autor principal: Sanchez-Ramirez, Diana C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780231/
https://www.ncbi.nlm.nih.gov/pubmed/35054101
http://dx.doi.org/10.3390/jcm11020407
_version_ 1784637786718994432
author Sanchez-Ramirez, Diana C.
author_facet Sanchez-Ramirez, Diana C.
author_sort Sanchez-Ramirez, Diana C.
collection PubMed
description Background: the effect of pulmonary rehabilitation (PR) services, beyond research contexts, on patients with lung diseases other than COPD requires further study. Objectives: to (i) assess the impact of a publicly funded PR on patients’ exercise capacity, self-efficacy, and health-related quality of life (HRQoL), and (ii) explore whether the effects vary across lung diseases. Methods: this retrospective pre–post study analyzed data from the Winnipeg Regional Health Authority PR program between 2016 and 2019. Results: 682 patients completed the full PR program. Pooled analyses found significant improvements in the patients’ exercise capacity (six-minute walk test (6MWT) (13.6%), fatigue (10.3%), and dyspnea (6.4%)), Self-Efficacy for Managing Chronic Disease 6-Item Scale (SEMCD6) (11.6%), and HRQoL (Clinical COPD Questionnaire (CCQ) (18.5%) and St George’s Respiratory Questionnaire (SGRQ) (10.9%)). The analyses conducted on sub-groups of patients with chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, interstitial lung diseases (ILDs), other restrictive lung diseases (e.g., obesity, pleural effusion, etc.), lung cancer, and pulmonary hypertension (PH) indicated that, except for patients with PH, all the patients improved in the 6MWT. Fatigue decreased in patients with COPD, ILDs, and other restrictive lung diseases. Dyspnea decreased in patients with COPD, asthma, and lung cancer. SEMCD6 scores increased in COPD, ILDs and PH patients. CCQ scores decreased in all lung diseases, except lung cancer and PH. SGRQ scores only decreased in patients with COPD. Conclusion: PR services had a significant impact on patients with different lung diseases. Therefore, publicly funded PR should be available as a critical component in the management of patients with these diseases.
format Online
Article
Text
id pubmed-8780231
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87802312022-01-22 Impact of Pulmonary Rehabilitation Services in Patients with Different Lung Diseases Sanchez-Ramirez, Diana C. J Clin Med Article Background: the effect of pulmonary rehabilitation (PR) services, beyond research contexts, on patients with lung diseases other than COPD requires further study. Objectives: to (i) assess the impact of a publicly funded PR on patients’ exercise capacity, self-efficacy, and health-related quality of life (HRQoL), and (ii) explore whether the effects vary across lung diseases. Methods: this retrospective pre–post study analyzed data from the Winnipeg Regional Health Authority PR program between 2016 and 2019. Results: 682 patients completed the full PR program. Pooled analyses found significant improvements in the patients’ exercise capacity (six-minute walk test (6MWT) (13.6%), fatigue (10.3%), and dyspnea (6.4%)), Self-Efficacy for Managing Chronic Disease 6-Item Scale (SEMCD6) (11.6%), and HRQoL (Clinical COPD Questionnaire (CCQ) (18.5%) and St George’s Respiratory Questionnaire (SGRQ) (10.9%)). The analyses conducted on sub-groups of patients with chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, interstitial lung diseases (ILDs), other restrictive lung diseases (e.g., obesity, pleural effusion, etc.), lung cancer, and pulmonary hypertension (PH) indicated that, except for patients with PH, all the patients improved in the 6MWT. Fatigue decreased in patients with COPD, ILDs, and other restrictive lung diseases. Dyspnea decreased in patients with COPD, asthma, and lung cancer. SEMCD6 scores increased in COPD, ILDs and PH patients. CCQ scores decreased in all lung diseases, except lung cancer and PH. SGRQ scores only decreased in patients with COPD. Conclusion: PR services had a significant impact on patients with different lung diseases. Therefore, publicly funded PR should be available as a critical component in the management of patients with these diseases. MDPI 2022-01-14 /pmc/articles/PMC8780231/ /pubmed/35054101 http://dx.doi.org/10.3390/jcm11020407 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sanchez-Ramirez, Diana C.
Impact of Pulmonary Rehabilitation Services in Patients with Different Lung Diseases
title Impact of Pulmonary Rehabilitation Services in Patients with Different Lung Diseases
title_full Impact of Pulmonary Rehabilitation Services in Patients with Different Lung Diseases
title_fullStr Impact of Pulmonary Rehabilitation Services in Patients with Different Lung Diseases
title_full_unstemmed Impact of Pulmonary Rehabilitation Services in Patients with Different Lung Diseases
title_short Impact of Pulmonary Rehabilitation Services in Patients with Different Lung Diseases
title_sort impact of pulmonary rehabilitation services in patients with different lung diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780231/
https://www.ncbi.nlm.nih.gov/pubmed/35054101
http://dx.doi.org/10.3390/jcm11020407
work_keys_str_mv AT sanchezramirezdianac impactofpulmonaryrehabilitationservicesinpatientswithdifferentlungdiseases